Who Exports Soframycin from India — 63 Suppliers Behind a $598.8K Market
India's soframycin export market is supplied by 63 active exporters who collectively shipped $598.8K across 243 shipments. ENCUBE ETHICALS PRIVATE LIMITED leads with a 79.1% market share, followed by CAPSTONE EXPORT & IMPORT and S. HIMATLAL HEALTHCARE LLP. The top 5 suppliers together control 84.5% of total export value, reflecting a concentrated market structure.
Top Soframycin Exporters from India — Ranked by Export Value
ENCUBE ETHICALS PRIVATE LIMITED is the leading soframycin exporter from India, holding a 79.1% share of the $598.8K market across 243 shipments from 63 exporters. The top 5 suppliers — ENCUBE ETHICALS PRIVATE LIMITED, CAPSTONE EXPORT & IMPORT, S. HIMATLAL HEALTHCARE LLP, VEA IMPEX (I) PRIVATE LIMITED, NU HOSPITALS PRIVATE LIMITED — collectively control 84.5% of total export value, indicating a highly concentrated market. Individual shares are: ENCUBE ETHICALS PRIVATE LIMITED (79.1%), CAPSTONE EXPORT & IMPORT (3.1%), S. HIMATLAL HEALTHCARE LLP (1.9%), VEA IMPEX (I) PRIVATE LIMITED (0.2%), NU HOSPITALS PRIVATE LIMITED (0.2%).
Top Soframycin Exporters from India
Ranked by export value · 63 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | ENCUBE ETHICALS PRIVATE LIMITED SOFRAMYCIN CREAM 20GM TUBESOFRAMYCIN CREAM 20GM TUBE B.NO.3CH302 , | $473.5K | 3 | 79.1% |
| 2 | CAPSTONE EXPORT & IMPORT SOFRAMYCIN CREAMFRAMYCETIN SOFRAMYCIN CREAM 30G | $18.8K | 1 | 3.1% |
| 3 | S. HIMATLAL HEALTHCARE LLP SOFRAMYCIN CREAMSOFRAMYCIN CREAM [6000 TUB X 30GM = 6000 | $11.4K | 1 | 1.9% |
| 4 | VEA IMPEX (I) PRIVATE LIMITED SOFRAMYCIN CREAMFRAMYCETIN SOFRAMYCIN CREAM 30G | $1.2K | 1 | 0.2% |
| 5 | NU HOSPITALS PRIVATE LIMITED FRAMYCETIN SULPHATE - SKIN CREAM - 1%W/W - SOFRAMYCINSOFRAMYCIN 30GMSOFRAMYCIN CREAM (PHARMACEUTICALS, | $1.1K | 1 | 0.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Soframycin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| ENCUBE ETHICALS PRIVATE LIMITED | Approved | Yes (April 2019) | Yes | 72 | FDA-approved manufacturer with WHO-GMP and EU GMP certifications; holds 72 ANDAs |
TransData Nexus reviewed the regulatory standing of 1 leading Soframycin exporters from India. 1 hold US FDA facility approvals, 1 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Soframycin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories and Aurobindo Pharma. The city's Genome Valley is India's first biotech cluster, fostering advanced R&D infrastructure and a skilled talent pool. This ecosystem supports the production of active pharmaceutical ingredients (APIs), vaccines, biologics, and biosimilars, making Hyderabad a pivotal hub for bulk drug manufacturing.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat contributes nearly 28% of India's pharmaceutical production. Home to companies like Zydus Cadila and Torrent Pharmaceuticals, this region specializes in the manufacturing of pharmaceutical formulations. The robust infrastructure, including ports and transportation networks, coupled with a strong regulatory framework, positions this cluster as a leader in the production of finished dosage forms.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceuticals. With 929 pharmaceutical units, the region boasts a well-established industrial base and proximity to major ports, facilitating efficient export operations. The presence of multinational corporations and a skilled workforce further enhances its role in the global pharmaceutical supply chain.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is recognized as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth has been propelled by favorable government policies, including tax incentives and infrastructure development. Baddi's strategic location and cost-effective manufacturing capabilities make it a significant contributor to India's pharmaceutical exports.
5Sourcing Recommendations
- Diversify Supplier Base: While Encube Ethicals Private Limited dominates Soframycin exports, exploring partnerships with other manufacturers in regions like Hyderabad and Ahmedabad-Vadodara can mitigate supply chain risks.
- Leverage Export Infrastructure: Utilize the export capabilities of the Mumbai-Thane-Raigad cluster to enhance distribution efficiency and access to international markets.
- Optimize Cost Structures: Consider sourcing from Baddi-Nalagarh to benefit from tax incentives and cost-effective manufacturing, thereby improving profit margins.
- Strengthen Regulatory Compliance: Engage with suppliers in clusters known for stringent regulatory adherence, such as Ahmedabad-Vadodara, to ensure product quality and compliance with international standards.
By strategically engaging with these pharmaceutical clusters, TransData Nexus can enhance its supply chain resilience and capitalize on India's robust pharmaceutical manufacturing capabilities.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Soframycin exporters from India
Encube Ethicals Private Limited — Warburg Pincus and Mubadala lead bid for Encube Ethicals stake
A consortium led by Warburg Pincus and Abu Dhabi's Mubadala has emerged as the frontrunner to acquire up to a 74% stake in Encube Ethicals, valuing the company at approximately ₹16,500 crore ($1.8 billion). The deal is expected to be finalized in the coming weeks. - IMPACT: This acquisition is anticipated to bolster Encube Ethicals' financial position, potentially enhancing its Soframycin export capabilities.
Impact: This acquisition is anticipated to bolster Encube Ethicals' financial position, potentially enhancing its Soframycin export capabilities.
Common Questions — Soframycin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which soframycin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, ENCUBE ETHICALS PRIVATE LIMITED leads with 19 recorded shipments worth $473.5K. CAPSTONE EXPORT & IMPORT (10 shipments) and S. HIMATLAL HEALTHCARE LLP (16 shipments) are also established high-volume exporters.
Q How many soframycin manufacturers are there in India?
India has 63 active soframycin exporters with a combined export market of $598.8K across 243 shipments to 36 countries. The top 5 suppliers hold 84.5% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for soframycin from India?
Average FOB unit price: $3.86 per unit, ranging from $0.18 to $183.93. Average shipment value: $2.5K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 63 verified Indian exporters of Soframycin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 243 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 36 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
243 Verified Shipments
63 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists